.jpg)
BreachRx, the leader in governed cyber incident response management (CIRM), has appointed Young-Sae Song as Chief Marketing Officer. Song will lead global marketing, brand development, and go-to-market strategy as the company scales its mission to transform incident response from reactive, fragmented efforts into a structured, enterprise-wide operating process with governance, accountability, and regulatory readiness.
Song brings a proven track record of shaping emerging cybersecurity markets, building repeatable go-to-market engines, and guiding companies from early adoption to broad market leadership. His experience aligns with BreachRx’s goal of elevating incident response to a strategic, cross-functional discipline that reduces decision latency, regulatory exposure, and operational fragmentation.
“Cyber incidents are no longer rare events — they are an everyday operating reality. What separates resilient organizations from everyone else is how reliably they can respond under pressure,” said Young-Sae Song. “BreachRx gives enterprises a single place to orchestrate response, align executives and practitioners, and document every action with the precision regulators and Boards expect. I am excited to help scale our go-to-market strategy and bring clarity, vision, and operational rigor to a function that has long needed it.”
“The limiting factor in incident response is no longer just detection—it’s decision latency, fragmented coordination, and regulatory complexity,” said Anderson Lunsford, CEO and Co-founder of BreachRx. “Young-Sae's deep experience scaling high-growth cybersecurity companies and defining new categories will accelerate awareness of a critical shift already underway: incident response must operate with the same rigor, evidence, and accountability as any other core enterprise function. We are thrilled to welcome him to the team.”
Modern cyber incidents involve rapid escalation, multiple stakeholders, and complex regulatory requirements that manual coordination cannot handle effectively. BreachRx addresses this by providing a patented platform that orchestrates every phase—preparation, response, and post-incident—with automated plans, guided actions, real-time evidence capture, and a system of record for auditability and disclosure readiness. This approach minimizes legal and financial exposure while enhancing enterprise resilience.
The company continues to expand its capabilities through innovations like Rex AI™ for intelligent response guidance, the Mobile Command app for on-the-go coordination, and Cyber RegScout™ for tracking global breach notification laws. Song’s appointment positions BreachRx to accelerate adoption among enterprises seeking to modernize incident response as a repeatable, governed process.
About BreachRx
BreachRx is the first platform built to run cyber incident response as a governed, enterprise-wide business process. Its patented technology orchestrates every phase of response—before, during, and after an incident—automatically generating tailored plans, guiding stakeholders through each step, and capturing evidence in real time. With a single authoritative system for incident status, ownership, auditability, and disclosure readiness, BreachRx ensures operational resilience for the entire enterprise while reducing regulatory and legal exposure. BreachRx is based in San Francisco and backed by Ballistic Ventures and SYN Ventures.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.